Med Business World

Your source for healthcare business

SputnikV vaccine

The Gamaleya Center has developed a Delta- and Omicron-adapted Sputnik V vaccine

The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announce the development of the Sputnik V vaccine specifically adapted against Delta and Omicron variants of coronavirus.Over the course of the pandemic the…